Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A Unique Manifestation of Pupillary Fatigue in Autoimmune Autonomic Ganglionopathy.
Muppidi S, Scribner M, Gibbons CH, Adams-Huet B, Spaeth EB, Vernino S.
Arch Neurol. 2012 Jan 9. [Epub ahead of print]
Related citations
Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.
Pool V, Gordon DM, Decker M.
Arch Neurol. 2012 Jan;69(1):144; author reply 144-5. No abstract available.
Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
Marcus JF, Shalev SM, Harris CA, Goodin DS, Josephson SA.
Arch Neurol. 2012 Jan;69(1):129-32.
Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
Caramanos Z, Francis SJ, Narayanan S, Lapierre Y, Arnold DL.
Arch Neurol. 2012 Jan;69(1):89-95.
Impact of inflammation on brain volume in multiple sclerosis.
Cheriyan J, Kim S, Wolansky LJ, Cook SD, Cadavid D.
Arch Neurol. 2012 Jan;69(1):82-8.
Daclizumab use in patients with pediatric multiple sclerosis.
Gorman MP, Tillema JM, Ciliax AM, Guttmann CR, Chitnis T.
Arch Neurol. 2012 Jan;69(1):78-81.
Autoimmune autonomic ganglionopathy with reversible cognitive impairment.
Gibbons CH, Centi J, Vernino S, Freeman R.
Arch Neurol. 2012 Apr;69(4):461-6. Epub 2011 Dec 12.
Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis.
Richman DP.
Arch Neurol. 2012 Apr;69(4):434-5. Epub 2011 Dec 12. No abstract available.
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
Zhang B, Tzartos JS, Belimezi M, Ragheb S, Bealmear B, Lewis RA, Xiong WC, Lisak RP, Tzartos SJ, Mei L.
Arch Neurol. 2012 Apr;69(4):445-51. Epub 2011 Dec 12.
Propylthiouracil-induced lupus, antiphospholipid syndrome, and stroke in a patient with Graves hyperthyroidism.
Ortiz GA, Lagari-Libhaber V, Prieto-Sanchez LM, Rabinstein AA.
Arch Neurol. 2011 Dec;68(12):1587-90.
Magnetic resonance techniques in multiple sclerosis: the present and the future.
Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, Inglese M, Pelletier D, Comi G.
Arch Neurol. 2011 Dec;68(12):1514-20. Review.
No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model.
Williams MA, Venkatesan A.
Arch Neurol. 2011 Dec;68(12):1510-2. No abstract available.
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Tur C, Montalban X, Tintoré M, Nos C, Río J, Aymerich FX, Brieva L, Téllez N, Perkal H, Comabella M, Galán I, Calle D, Sastre-Garriga J, Rovira A.
Arch Neurol. 2011 Nov;68(11):1421-7.
Ring sign on diffusion-weighted imaging.
Finelli PF, Uphoff DF.
Arch Neurol. 2011 Nov;68(11):1474-5. No abstract available.
Brain involvement in neuromyelitis optica spectrum disorders.
Chan KH, Tse CT, Chung CP, Lee RL, Kwan JS, Ho PW, Ho JW.
Arch Neurol. 2011 Nov;68(11):1432-9.
Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.
Saure C, Warnke C, Zohren F, Schroeder T, Bruns I, Cadeddu RP, Weigelt C, Fischer U, Kobbe G, Hartung HP, Adams O, Kieseier BC, Haas R.
Arch Neurol. 2011 Nov;68(11):1428-31.
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.
Kim SH, Kim W, Li XF, Jung IJ, Kim HJ.
Arch Neurol. 2011 Nov;68(11):1412-20. Epub 2011 Jul 11.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.
Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH; Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance Investigators.
Arch Neurol. 2012 Feb;69(2):183-90. Epub 2011 Oct 10.
Postvaccination Miller Fisher syndrome.
Shoamanesh A, Chapman K, Traboulsee A.
Arch Neurol. 2011 Oct;68(10):1327-9. Review.
The TH1/TH2 paradigm in Guillain-Barré syndrome.
Zhang HL, Li HF.
Arch Neurol. 2011 Sep;68(9):1209; author reply 1209-10. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on